Streetbeat News

Earnings

CORT

Corcept Therapeutics is set to announce its quarterly earnings on October 30, 2024, with analysts estimating an EPS of $0.28. Investors are keen on not just an earnings beat but also positive future guidance. Despite past EPS beats, the stock has seen mixed price reactions. Analysts rate Corcept as a 'Buy' with a price target of $75.25, indicating a potential upside. The company shows strong revenue growth but lags in gross profit and return on equity compared to peers.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 4:01 pm

FI

Fiserv (NYSE:FI) has received 22 analyst ratings in the past three months, with a mix of bullish and somewhat bullish perspectives. The average 12-month price target has increased by 15.28% to $212.55. Analysts have raised their price targets, reflecting positive sentiment. Despite this, Fiserv's financial performance shows challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 4:00 pm

AMPX

Amprius Technologies shares are trading higher following the release of their preliminary Q3 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 3:46 pm

HOOD

Financial giants are showing a bullish trend in Robinhood Markets (NASDAQ:HOOD) with 72% of options trades being bullish. The stock is currently trading at $28.0, slightly up by 0.43%. Analysts have mixed ratings with price targets ranging from $21 to $27. The anticipated earnings release is in 1 day.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:45 pm

SPOT

The options market for Spotify Technology (NYSE:SPOT) shows a bullish trend with significant trades, including 7 call options valued at $1,026,245 and 6 put options valued at $269,916. Analysts have mixed ratings, with price targets ranging from $340 to $490. SPOT's stock is currently trading at $389.92, up 1.45%, with an earnings announcement expected in 14 days.

Portfolio Pulse from Benzinga Insights

October 29, 2024 | 3:30 pm

ASML

ASML Holding NV's stock has dropped 15% in October due to a downward revision of its 2025 sales forecast, despite strong Q3 results. The company expects softer demand outside AI and high-performance computing, impacting its growth trajectory.

Portfolio Pulse from Henry Khederian

October 29, 2024 | 3:24 pm

F

Ford Motor Co's stock is under pressure following its Q3 earnings report. Despite revenue and EPS beating estimates, the company's soft earnings outlook and challenges in the EV segment are concerning investors. Analysts have adjusted their price targets, reflecting cautious sentiment.

Portfolio Pulse from Adam Eckert

October 29, 2024 | 3:21 pm

ON

ON Semiconductor reported solid Q3 results with revenues slightly above expectations, but guidance for a flat Q4 due to ongoing demand weakness. Analysts have mixed views, with some lowering price targets while maintaining Buy ratings, and others highlighting potential growth in the data center and EV markets.

Portfolio Pulse from Priya Nigam

October 29, 2024 | 3:17 pm

TALK

Talkspace shares are trading higher after the company reported a Q3 EPS beat, even though it slightly missed on revenues.

Portfolio Pulse from Benzinga Newsdesk

October 29, 2024 | 3:12 pm

WGS

GeneDx Holdings (NASDAQ:WGS) reported a narrower Q3 loss and increased revenues, leading to a significant stock price rise. The company beat earnings and revenue expectations, with a notable 77% growth in exome and genome test revenues. GeneDx also improved its adjusted gross margin and achieved positive adjusted net income. The company raised its 2024 revenue guidance, further boosting investor confidence.

Portfolio Pulse from Vandana Singh

October 29, 2024 | 3:11 pm